Skip to main content

Table 5 Spearman’s correlation analysis between KIF5 members when normalized to GAPDH in human AD frontal cortex samples

From: Normal levels of KIF5 but reduced KLC1 levels in both Alzheimer disease and Alzheimer disease in Down syndrome: evidence suggesting defects in anterograde transport

Sample type

  

Sample size (n)

Correlation coefficient (r)

Significance (P)

C/AD and AD

KIF5A

KIF5B

24

0.6113

0.0015**

C/AD and AD

KIF5A

KIF5C

24

0.8991

< 0.0001***

C/AD and AD

KIF5B

KIF5C

24

0.6252

0.0011**

AD

KIF5A

KIF5B

12

0.6084

0.0358*

AD

KIF5A

KIF5C

12

0.8462

0.0005***

AD

KIF5B

KIF5C

12

0.7413

0.0058**

C/AD

KIF5A

KIF5B

12

0.6713

0.0168*

C/AD

KIF5A

KIF5C

12

0.9301

< 0.0001***

C/AD

KIF5B

KIF5C

12

0.5455

0.0666